Announcing the Kraken $100M+ volume fee tier trial

[ad_1]

Starting December 15, 2022 0:00 UTC through February 15, 2022 11:59 UTC*, we will offer 0% maker and 0.08% taker fees on select spot pairs to qualifying clients as part of our $100M+ volume fee tier trial.

Who is eligible?

All clients who trade over $100M in total spot crypto volume on a 30-day rolling basis will automatically be placed in the trial’s new fee tier.

Trading volume is calculated across all traded pairs with the exception of markets where stablecoins or fiat currencies are the base currency (the first currency listed in a pair – in USDC/USD, USDC is the base currency). Click here for more info on how trading fees for our stablecoins and FX pairs work.

The 30-day rolling volume is computed on a continuous basis.

What Kraken platforms are included in the trial?

The trial applies to pairs that are traded directly on spot order books, including via mobile, web and API, but does not include pairs traded on the Kraken Consumer App or Kraken Futures.

How do the trial’s fees differ from Kraken’s stated fees?

We charge a fee when we match client orders. The fee ranges from 0% (0 bps) to 0.26% (26 bps) of the total cost (value) of your order and depends on the following:

For this trial, we’re introducing the $100M+ volume fee tier as part of our spot crypto trading fee schedule. Clients who reach $100M in 30-day trading volume will now incur 8 bps (instead of 10 bps) taker fees when trading the 309 spot pairs included in the trial.

The trial will run on 50% of crypto pairs offered on Kraken from December 15, 2022 0:00 UTC through February 15, 2022 11:59 UTC.

How can I confirm I’m eligible?

All clients are eligible as long as they meet the required volume threshold.

The easiest way to tell if you’re eligible is via your Fee Schedule (Fees) progress bar. You can keep track of your current fees and progress toward lower fees by looking at the Fees progress bar in your account overview:

  • Select the Kraken logo on the upper left when you are logged in to your account
  • Scroll down below trade balances

Please note that the fee schedule progress bar is market-specific and will only show fees that apply to your currently selected market:

Don’t hesitate to reach out to an account manager or Kraken support if you have any questions about participation in the trial. Our teams are available 24/7.

Why is Kraken running this trial?

This trial will enable client strategies that are extremely fee-sensitive and allow us to assess the overall impact on order book liquidity. We will also be able to see how the new fees impact our trading ecosystem.

Which spot trading pairs will be included and why?

Included trading pairs provide the trial with 50% coverage of our markets, both in terms of number of markets and trading volume.

In order to programmatically determine which pairs are included in the trial, you can call the /AssetPairs public endpoint on our REST API, where fees for a specific pair will be returned as part of the Fees array.

Click here for more info on how to use our API. Click here for our REST API documentation.

Contact your account manager or Kraken support with any questions.

The following 309 spot pairs will be included in the trial:


*Kraken reserves the right to change the end date of the $100M+ fee tier trial. Participants will be notified by Kraken in the event of such a change.

These materials are for general information purposes only and are not investment advice or a recommendation or solicitation to buy, sell or hold any cryptoasset or to engage in any specific trading strategy. Some crypto products and markets are unregulated, and you may not be protected by government compensation and/or regulatory protection schemes. The unpredictable nature of the cryptoasset markets can lead to loss of funds. Tax may be payable on any return and/or on any increase in the value of your cryptoassets and you should seek independent advice on your taxation position.

[ad_2]

Image and article originally from blog.kraken.com.
Read the original article here.